Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
Michael Bennett;Hermine Brunner, MD |
Innovative Efficacy Measures of Lupus Nephritis Therapies |
National Institutes of Health |
U01 AR065098 |
7/26/2013 - 6/30/2017 |
$148,023 |
Donna Claes, MD |
Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease |
National Institutes of Health (Nationwide Children's Hospital) |
UM1 DK100866 |
6/1/2014 - 5/31/2016 |
$10,420 |
Prasad Devarajan, MD |
2013 Medical Student Summer Research Program |
National Institutes of Health |
P50 DK096418 |
9/21/2012 - 8/31/2017 |
$43,680 |
Prasad Devarajan, MD |
Critical Translational Studies in Pediatric Nephrology |
National Institutes of Health (Ntl Inst of Diab & Digest & Kidney Dis) |
P50 DK096418 |
9/21/2012 - 8/31/2017 |
$741,986 |
Prasad Devarajan, MD |
Novel Serum and Urinary Biomarkers of Diabetic Kidney Disease |
National Institutes of Health (Mount Sinai Hospital) |
R01 DK096549 |
10/1/2014 - 6/30/2017 |
$14,927 |
Prasad Devarajan, MD |
Novel Biomarkers in Cardiac Surgery to Detect Acute Kidney Injury |
National Institutes of Health (Yale University School of Medicine) |
R01 HL085757 |
4/12/2012 - 3/31/2017 |
$44,819 |
Prasad Devarajan, MD |
Research Training in Pediatric Nephrology |
National Institutes of Health |
T32 DK007695 |
7/1/2014 - 6/30/2019 |
$65,842 |
Prasad Devarajan, MD |
Progression of Acute Kidney Injury to Chronic Kidney Disease |
National Institutes of Health (Yale University School of Medicine) |
U01 DK082185 |
9/19/2013 - 6/30/2018 |
$30,600 |
Bradley Patton Dixon, MD |
A Novel Mechanism for Regulation of Renal Urea Transport |
University of Cincinnati |
UC_Dixon-Siroky |
4/1/2015 - 5/1/2017 |
$8,465 |
Stuart Goldstein, MD |
Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care |
National Institutes of Health (Duke University) |
HHSN-2752010000031 |
4/1/2013 - 2/24/2017 |
$1,035,000 |
Stuart Goldstein, MD |
Recombinant Erythropoietin Protects Against Kidney Disease (REPAKD) |
National Institutes of Health (Children's Hosp & Reg Med Ct-Seattle) |
R01 DK103608 |
9/17/2014 - 8/31/2019 |
$17,901 |
Stuart Goldstein, MD |
Phase-II IDE G090189-11/6/13: Pediatric ICU Patients wit |
Food and Drug Administration (Innovative BioTherapies, Inc.) |
R01 FD005092 |
9/10/2015 - 8/31/2019 |
$265,790 |
Stuart Goldstein, MD |
Reduction of Nephrotoxic Medication-Associated Acute Kidney Injury in Children |
Agcy for Healthcare Research and Quality |
R18 HS023763 |
4/1/2015 - 3/31/2018 |
$498,321 |
Gilad Hamdani, MD |
Donor specific Antibody IgG Subclasses and Antibody-Mediated Rejection Risk in Children Post Kidney Transplantation |
Casey Lee Ball Foundation |
Casey Lee Ball - Ham |
8/19/2015 - 8/18/2016 |
$10,000 |
Mark M Mitsnefes, MD |
Cardiovascular Disease in Children with Chronic Kidney D |
National Institutes of Health |
K24 DK090070 |
7/1/2011 - 6/30/2017 |
$160,391 |
Mark M Mitsnefes, MD |
Chronic Kidney Disease in Children (CKiD III) |
National Institutes of Health (Children's Mercy Hospital) |
U01 DK066143 |
8/1/2013 - 7/31/2018 |
$236,218 |
Total Annual Grant Award Dollars |
$3,332,383 |